CCMH
SCLN

Cornerstone Capital Management Holdings’s Sciclone Pharmaceuticals Inc SCLN Stock Holding History

Cornerstone Capital Management Holdings’s Portfolio SCLN Stock Details SCLN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-108,779
Closed -$1.2M – 1365
2017
Q2 		$1.2M Sell
108,779
-105,696
-49% -$1.06M 0.01% 862
2017
Q1 		$2.1M Sell
214,475
-79,495
-27% -$794K 0.02% 714
2016
Q4 		$3.17M Sell
293,970
-122,300
-29% -$1.22M 0.02% 611
2016
Q3 		$4.27M Buy
416,270
+144,900
+53% +$1.58M 0.03% 511
2016
Q2 		$3.54M Buy
271,370
+35,500
+15% +$465K 0.03% 546
2016
Q1 		$2.6M Buy
235,870
+37,300
+19% +$332K 0.02% 656
2015
Q4 		$1.83M Buy
198,570
+48,470
+32% +$406K 0.02% 761
2015
Q3 		$1.04M Buy
150,100
+134,700
+875% +$1.15M 0.01% 872
2015
Q2 		$151K Buy
15,400
+14,100
+1,085% +$128K ﹤0.01% 1244
2015
Q1 		$12K Buy
+1,300
New +$10.4K ﹤0.01% 1356
2014
Q3 		– Sell
-13,300
Closed -$69K – 1393
2014
Q2 		$69K Sell
13,300
-6,900
-34% -$33.6K ﹤0.01% 1220
2014
Q1 		$92K Sell
20,200
-23,145
-53% -$112K ﹤0.01% 1203
2013
Q4 		$218K Sell
43,345
-14,200
-25% -$68.3K ﹤0.01% 1039
2013
Q3 		$292K Sell
57,545
-36,055
-39% -$201K ﹤0.01% 999
2013
Q2 		$465K Buy
+93,600
New +$445K 0.01% 930

Other funds holding SCLN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
GP
GLG Partners London, United Kingdom $2.14B AUM 21.14% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
MWNA
Marshall Wace North America New York $23.5B AUM 46.46% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Cornerstone Capital Management Holdings's SCLN Position: Q3 2017 in Review

Cornerstone Capital Management Holdings sold out of Sciclone Pharmaceuticals Inc (SCLN) in Q3 2017, closing a stake of 108,779 shares — an estimated $1.2M sold.

Cornerstone Capital Management Holdings first reported a position in SCLN in Q2 2013 and held it in 15 quarters. The position peaked at $4.27M in Q3 2016. 129 funds tracked by Wall St. Rank hold SCLN as of Q3 2017.

  • Cornerstone Capital Management Holdings reported no remaining Sciclone Pharmaceuticals Inc position as of Q3 2017 after selling out during the quarter.
  • Cornerstone Capital Management Holdings sold 108,779 Sciclone Pharmaceuticals Inc shares in Q3 2017, an estimated $1.2M.
  • Cornerstone Capital Management Holdings first reported a position in Sciclone Pharmaceuticals Inc in Q2 2013 and held it in 15 quarters.
  • Cornerstone Capital Management Holdings's Sciclone Pharmaceuticals Inc position peaked at $4.27M in Q3 2016.
  • 129 funds tracked by Wall St. Rank held Sciclone Pharmaceuticals Inc as of Q3 2017.

Based on Cornerstone Capital Management Holdings's 13F filing for Q3 2017, filed 14 Nov 2017.